Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms

Oncogene

Volumn 31, Issue 11, 2012, Pages 1389-1397

  Khromova, N ^a   Kopnin, P ^a   Rybko, V ^a   Kopnin, B P ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

cancer stem cells (CSCs); cell migration; epithelial?mesenchymal transition(EMT); metastasis; tumor vascularization; VEGF C

Indexed keywords

VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER STEM CELL; CELL INVASION; CELL POPULATION; CELL PROLIFERATION; CELL STRAIN HCT116; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG CARCINOMA; LUNG LOBE; LYMPHANGIOGENESIS; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84858335983     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.330     Document Type: Article

References (36)

1. Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. (2003). Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 97: 457-464.
2. Bahram F, Claesson-Welsh L. (2010). VEGF-mediated signal transduction in lymphatic endothelial cells. Pathophysiology 17: 253-261.
3. Chen Y, Jiang L, She F, Tang N, Wang X, Li X et al. (2010). Vascular endohelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism. Mol Cell Biochem 345: 77-89.
4. Gu Y, Qi X, Guo S. (2008). Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: A retrospective study of 61 cases. Clin Exp Metastasis 25: 717-725.
5. Guarino M, Rubino B, Ballabio G. (2007). The role of epithelialmesenchymal transition in cancer pathology. Pathology 39: 305-318.
6. Gupta PB, Chaffer CL, Weinberg RA. (2009). Cancer stem cells: Mirage or reality? Nat Med 15: 1010-1012.
7. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T et al. (2002). Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94: 819-825.
8. Hoshida T, Isaka N, Hagendoorn J, di Tomaso E, Chen YL, Pytowski B et al. (2006). Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: Therapeutic implications. Cancer Res 66: 8065-8075.
9. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED et al. (2007). Epithelial-mesenchymal and mesenchymalepithelial transitions in carcinoma progression. J Cell Physiol 213: 374-383.
10. Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C et al. (2002). A potential autocrine role for vascular endothelial growth factor in prostate cancer. Cancer Res 62: 854-859.
11. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E et al. (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 290-298.
12. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y et al. (1997). Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16: 3898-3911.
13. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K et al. (2001). A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 98: 12677-12682.
14. Karpanen T, Heckman C, Keskitalo S, Jeltsch M, Ollila H, Alitalo K. (2006). Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20: 1462-1472.
15. Khromova NV, Kopnin PB, Stepanova EV, Agapova LS, Kopnin BP. (2009). p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway. Cancer Lett 276: 143-151.
16. Kodama M, Kitadai Y, Tanaka M, Kuwai T, Tanaka S, Oue N et al. (2008). Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Clin Cancer Res 14: 7205-7214.
17. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R et al. (2001). Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20: 672-682.
18. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
19. Miyazaki T, Okada N, Ishibashi K, Ogata K, Ohsawa T, Ishiguro T et al. (2008). Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer. Jpn J Clin Oncol 38: 839-843.
20. Orlandini M, Spreafico A, Bardelli M, Rocchigiani M, Salameh A, Nucciotti S et al. (2006). Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation. J Biol Chem 281: 17961-17967.
21. Polyak K, Weinberg RA. (2009). Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
22. Shibuya M, Claesson-Welsh L. (2006). Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312: 549-560.
23. Singh A, Settleman J. (2010). EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene 29: 4741-4751.
24. Skobe M, Brown LF, Tognazzi K, Ganju RK, Dezube BJ, Alitalo K et al. (1999). Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-Associated Kaposi's sarcoma. J Invest Dermatol 113: 1047-1053.
25. Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G et al. (2001). Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol 193: 468-475.
26. Su JL, Yang PC, Shih JY, Yang CY, Wei LH, Hsieh CY et al. (2006). The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9: 209-223.
27. Su JL, Chen PS, Chien MH, Chen PB, Chen YH, Lai CC et al. (2008). Further evidence for expression and function of the VEGF-C/ VEGFR-3 axis in cancer cells. Cancer Cell 13: 557-560.
28. Tammela T, Alitalo K. (2010). Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140: 460-476.
29. Thiery JP, Acloque H, Huang RY, Nieto MA. (2009). Epithelialmesenchymal transitions in development and disease. Cell 139: 871-890.
30. Timoshenko AV, Rastogi S, Lala PK. (2007). Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells. Br J Cancer 97: 1090-1098.
31. Wang X, Fu X, Hoffman RM. (1992). A patient-like metastasizing model of human lung adenocarcinoma constructed via thoracotomy in nude mice. Anticancer Res 12: 1399-1401.
32. Wu C, Alman BA. (2008). Side population cells in human cancers. Cancer Lett 268: 1-9.
33. Xu Y, Yuan L, Mak J, Pardanaud L, Caunt M, Kasman I et al. (2010). Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol 188: 115-130.
34. Yamashita T, Uramoto H, Onitsuka T, Ono K, Baba T, So T et al. (2010). Association between lymphangiogenesis-/micrometastasisand adhesion-related molecules in resected stage I NSCLC. Lung Cancer 70: 320-328.
35. Yamaura T, Murakami K, Doki Y, Sugiyama S, Misaki T, Yamada Y et al. (2000). Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer. Neoplasia 2: 315-324.
36. Zeisberg M, Neilson EG. (2009). Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437.